Eby defends his plan to tax the rich as campaigns tackle health care crisis - Global News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
BC NDP Leader David Eby is campaigning in Victoria on Monday, but an announcement he made on Sunday is generating a lot of reaction.
Eby announced that if his party is re-elected, he will introduce a new tax bracket for those who earn $1 million or more to help pay for health care. “We’re glad when people are successful; it’s fantastic,” Eby said. “We cheer for them; we want them to be successful. And it’s also right to ask people who earn a little bit more to pitch in in a moment like this, when people across the province need those strong public services.”Documents provided by the party say that the proposed changes would start in the 2027 tax year and are projected to raise $225 million in 2026/27, $925 million the next year, and $1 billion in the year after that. Story continues below advertisement
This article is an excerpt. To read the full content, visit the original source. Global News
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!